Enlarged Vestibular Aqueduct Syndrome (EVA) is an autosomal recessive deafness characterized by inner ear malformations. Pendred syndrome (PS) is an associated syndrome of EVA with goitrous change in the thyroid gland. Mutations in
SLC26A4, which encodes the pendrin protein, are common causes of EVA and PS. These syndromes follow an autosomal recessive pattern of inheritance. Recently, a few studies have reported another type of inheritance for these syndromes.
Here, we report a heterozygous
SLC26A4 c.919–2A>G (IVS7–2A>G) mutation in a patient with EVA. The patient presented with enlarged vestibular aqueduct in the CT scan and severe hearing loss in the auditory brainstem response (ABR) test, auditory steady-state response (ASSR) test, and conditioned orientation response audiometry (COR). Both, the genetic screening test for congenital hearing loss and next-generation sequencing (NGS) revealed only the presence of the heterozygous
SLC26A4 c.919–2A>G (IVS7–2A>G) mutation. Mutations in other genes associated with both EVA and PS (
FOXI1,
KCNJ10,
SIX1,
ATP6V1B1,
ATP6V0A4, and
POU3F4) and genes associated with hearing loss (
GJB2,
OTOF, and mitochondrial rRNA) were not detected by NGS under ClinVar at NCBI. Direct sequencing revealed that only the mother carried the heterozygous
SLC26A4 c.919–2A>G (IVS7–2A>G) mutation. A family pedigree analysis showed that the inheritance of hearing loss followed a non-autosomal recessive pattern that was dissimilar to the autosomal recessive pattern. The cause of hearing loss should differ between the patient and his mother because of the difference in their hearing pattern, despite no clear rejection of the mother's EVA by CT scan.
Most studies have reported an autosomal recessive inheritance pattern for EVA and PS, but a few studies have showed that digenic inheritance of double-heterozygous mutations induced another pattern of inheritance in the presence of
SLC26A4 mutations, as seen in this family. Thus, we cannot reject the possibility of inheritance induced by digenic double-heterozygous mutations along with heterozygous
SLC26A4 mutations or together with a mutation in the promoter region of
SLC26A4. However, the presence of the other accompanying mutation was not detected in our study. Therefore, we should consider genetic counseling with a medical geneticist if patients with EVA or PS show only heterozygous
SLC26A4 mutations.
View full abstract